NASDAQ: ONCY ONCOLYTICS BIOTECH INC 8-K

Oncolytics announces translational data on pelareorep to be presented at ASCO meeting

Filed May 22, 2026 · Period ending May 22, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ONCY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

View original filing on SEC.gov

Generated by AI · May 24, 2026 5:40 AM